[1] Merriman TR. An update on the genetic architecture of hyperuricemia and gout. Arthritis Res Ther , 2015, 17(1): 98.
[2] Merriman TR, Choi HK, Dalbeth N. The genetic basis of gout. Rheum Dis Clin North Am , 2014, 40(2): 279-290.
[3] Merriman TR, Dalbeth N. The genetic basis of hyperuricaemia and gout. Joint Bone Spine , 2011, 78(1): 35-40.
[4] Reginato AM, Mount DB, Yang I, Choi HK. The genetics of hyperuricaemia and gout. Nat Rev Rheumatol , 2012, 8(10): 610-621.
[5] Zhu YY, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum , 2011, 63(10): 3136-3141.
[6] Li J, Li YL, Huang Y. Epidemiologic study of hyperuricemia. Chin J Cardiovasc Med , 2010, 15(6): 415-417. 李静, 李雨璘, 黄艳. 高尿酸血症的流行病学研究. 中国心血管杂志, 2010, 15(6): 415-417.
[7] Tang YS, Liu H, Liu BC. Relfections on the basis of changes: theepidemiological data of hyperuricemia. Drug Eval , 2015(7): 8-13. 唐羽裳, 刘宏, 刘必成. 高尿酸血症流行病学数据的变迁及反思. 药品评价, 2015(7): 8-13.
[8] Oda M, Satta Y, Takenaka O, Takahata N. Loss of urate oxidase activity in hominoids and its evolutionary implications. Mol Bio Evol , 2002, 19(5): 640-653.
[9] Johnson RJ, Titte S, Cade JR, Rideout BA, Oliver WJ. Uric acid, evolution and primitive cultures. Semin Nephrol , 2005, 25(1): 3-8.
[10] Vitart V, Rudan I, Hayward C, Gray NK, Floyd J, Palmer CN, Knott SA, Kolcic I, Polasek O, Graessler J, Wilson JF, Marinaki A, Riches PL, Shu XH, Janicijevic B, Smolej-Narancic N, Gorgoni B, Morgan J, Campbell S, Biloglav Z, Barac-Lauc L, Pericic M, Klaric IM, Zgaga L, Skaric-Juric T, Wild SH, Richardson WA, Hohenstein P, Kimber CH, Tenesa A, Donnelly LA, Fairbanks LD, Aringer M, McKeigue PM, Ralston SH, Morris AD, Rudan P, Hastie ND, Campbell H, Wright AF. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet , 2008, 40(4): 437-442.
[11] Jordan KM, Cameron JS, Snaith M, Zhang WY, Doherty M, Seckl J, Hingorani A, Jaques R, Nuki G. British Society for R, British Health Professionals in Rheumatology Standards G, Audit Working G. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout. Rheumatology (Oxford) , 2007, 46(8): 1372-1374.
[12] Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, Pillinger MH, Merill J, Lee S, Prakash S, Kaldas M, Gogia M, Perez-Ruiz F, Taylor W, Lioté F, Choi H, Singh JA, Dalbeth N, Kaplan S, Niyyar V, Jones D, Yarows SA, Roessler B, Kerr G, King C, Levy G, Furst DE, Lawrence Edwards N, Mandell B, Ralph Schumacher H, Robbins M, Wenger N, Terkeltaub R. 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken) , 2012, 64(10): 1431-1446.
[13] Wilk JB, Djousse L, Borecki I, Atwood LD, Hunt SC, Rich SS, Eckfeldt JH, Arnett DK, Rao DC, Myers RH. Segregation analysis of serum uric acid in the NHLBI Family Heart Study. Hum Genet , 2000, 106(3): 355-359.
[14] Hediger MA, Johnson RJ, Miyazaki H, Endou H. Molecular physiology of urate transport. Physiology , 2005, 20(2): 125-133.
[15] Köttgen A, Albrecht E, Teumer A, Vitart V, Krumsiek J, Hundertmark C, Pistis G, Ruggiero D, O'Seaghdha CM, Haller T, Yang Q, Tanaka T, Johnson AD, Kutalik Z, Smith AV, Shi J, Struchalin M, Middelberg RP, Brown MJ, Gaffo AL, Pirastu N, Li G, Hayward C, Zemunik T, Huffman J, Yengo L, Zhao JH, Demirkan A, Feitosa MF, Liu X, Malerba G, Lopez LM, van der Harst P, Li X, Kleber ME, Hicks AA, Nolte IM, Johansson A, Murgia F, Wild SH, Bakker SJ, Peden JF, Dehghan A, Steri M, Tenesa A, Lagou V, Salo P, Mangino M, Rose LM, Lehtimäki T, Woodward OM, Okada Y, Tin A, Müller C, Oldmeadow C, Putku M, Czamara D, Kraft P, Frogheri L, Thun GA, Grotevendt
